Recent advancements in HAE treatments offer hope, but experts stress the need for more pediatric options and diverse therapies.
Michael Manning, MD
Advertisement
Michael Manning, MD: An allergy, asthma, & immunology specialist located in Arizona
Articles by Michael Manning, MD
At ACAAI 2025, Manning highlighted sustained attack reduction and strong patient preference for donidalorsen across long-term and switch data.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
2
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
3
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
4
What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD
5